艾迪加体部伽玛刀治疗非小细胞肺癌疗效观察

Clinical Efficacy of Ai-Di with Body-Gamma Knife in Treating Non-small Cell Lung Cancer

为了观察艾迪加体部伽玛刀治疗非小细胞肺癌的近期疗效及毒副反应,经临床、影像学和病理学诊断90例非小细胞肺癌,采用随机分组原则分为艾迪加体部伽玛刀治疗组和单纯体部伽玛刀治疗组.结果表明,治疗后3个月复查艾迪加体部伽玛刀治疗组总有效率和CR均略高于单纯体部伽玛刀治疗组;治疗后白细胞下降率分别为4.44%和17.78%,症状改善率分别为84.44%和62.22%,KPS提高率分别为62.22%和33.33%,组间差异性明显.可见,艾迪加体部伽玛刀治疗既能提高非小细胞肺癌的局部控制率,又能增强机体免疫功能.

Objective：To study Clinical effect of Ai-Di with Body-Gamma Knife in treating Non-small Cell Lung Cancer. Methods：Going through clinical.image and psychopathology ,90Non-small Cell Lung Cancer with random division into groups principle aredivided into Ai-Di add Body-Gamma Knife treatment group and merely Body-Gamma Knife treatment group. Resuit：After treating check in 3 months Ai-Di add Body Gamma Knife treatment group always effective rate and CR are higher than merely Body-Gamma Knife treatment group slightly. After treating white cell drop down to4.44 % and 17.78 %, Symptom improvement rateis 84.44 % and 62. 22% ,KPS improvement rateis 62. 22% and 33. 33%, the discrepancy of between blocks is obvious. Conclusion：Ai-Di add Body-Gamma Knife treatmentcan raise the local control rate of Non-small Cell Lung Cancer , and strengthen organism immunity function.